Standard Biotools (LAB) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 43.57% |
| 10 | Standard Biotools | 252.94 Mn | -223.78 Mn | 10.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.92% |
| Mar 31, 2026 | 47.54% |
| Dec 31, 2025 | -234.28% |
| Sep 30, 2025 | -395.02% |
| Jun 30, 2025 | -328.90% |
| Mar 31, 2025 | 29.24% |
| Sep 30, 2024 | 69.49% |
| Jun 30, 2024 | 51.29% |
| Mar 31, 2024 | 62.10% |
| Dec 31, 2023 | 35.26% |
| Sep 30, 2023 | -433.00% |
| Jun 30, 2023 | -330.26% |
| Mar 31, 2023 | -243.77% |
| Dec 31, 2022 | -99.26% |
| Sep 30, 2022 | -40.36% |
| Jun 30, 2022 | -198.93% |
| Mar 31, 2022 | -60.15% |
| Sep 30, 2021 | -185.47% |
| Jun 30, 2021 | -155.94% |
| Mar 31, 2021 | -183.70% |